Filing Details
- Accession Number:
- 0001181431-10-002798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-12 12:00:00
- Reporting Period:
- 2010-01-09
- Filing Date:
- 2010-01-12
- Accepted Time:
- 2010-01-12 19:17:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198237 | Phd P Alain Rolland | 10390 Pacific Center Court San Diego CA 92121 | Exec Vp, Product Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2010-01-09 | 3,073 | $3.45 | 56,141 | No | 4 | F | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2010-01-11 | 50,000 | $0.01 | 106,141 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2010-01-11 | 54,546 | $0.00 | 54,546 | $3.47 |
| Common Stock | Nonstatutory Stock Option (right to buy) | Acquisiton | 2010-01-11 | 95,454 | $0.00 | 95,454 | $3.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 334,546 | 2011-01-11 | 2020-01-10 | No | 4 | A | Direct |
| 430,000 | 2011-01-11 | 2020-01-10 | No | 4 | A | Direct |
Footnotes
- Represents shares withheld for taxes upon the release of restricted stock granted on January 9, 2009.
- Share were acquired pursuant to a restricted stock grant.
- The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
- This balance includes 80,250 of unvested restricted stock units.
Billionaire Hedge Funds
